Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Jan 27;5(1):12-14.
doi: 10.1016/j.jacbts.2019.12.002. eCollection 2020 Jan.

In-Stent Restenosis: Chasing Our Tails in Search of a Solution

Affiliations
Editorial

In-Stent Restenosis: Chasing Our Tails in Search of a Solution

Anna Lena Lahmann et al. JACC Basic Transl Sci. .
No abstract available

Keywords: liposomes; percutaneous coronary intervention; restenosis; ultrasound.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Early Atherosclerotic Lesion in an Animal Model Versus Late-Stage Human Fibroatheroma (A) Early-stage atherosclerotic lesion (schematic and Movat’s pentachrome stain) in the Yucatan miniswine (modified from Kim et al. [7]). (B) Late-stage human fibroatheroma (schematic and Movat‘s pentachrome stain).

Comment on

  • Stabilizing Peri-Stent Restenosis Using a Novel Therapeutic Carrier.
    Kee PH, Moody MR, Huang SL, Kim H, Yin X, Peng T, Laing ST, Klegerman ME, Rahbar MH, Vela D, Genstler C, Haworth KJ, Holland CK, McPherson DD. Kee PH, et al. JACC Basic Transl Sci. 2019 Nov 28;5(1):1-11. doi: 10.1016/j.jacbts.2019.09.005. eCollection 2020 Jan. JACC Basic Transl Sci. 2019. PMID: 32043017 Free PMC article.

References

    1. Otsuka F., Byrne R.A., Yahagi K. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015;36:2147–2159. - PubMed
    1. Marx N., Wohrle J., Nusser T. Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients. Circulation. 2005;112:2792–2798. - PubMed
    1. Hausleiter J., Kastrati A., Mehilli J. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation. 2004;110:790–795. - PubMed
    1. Kee P.H., Moody M.R., Huang S.-L. Stabilizing peri-stent restenosis using a novel therapeutic carrier. J Am Coll Cardiol Basic Trans Science. 2020;5:1–11. - PMC - PubMed
    1. Joner M., Byrne R.A. The importance of preclinical research in contemporary interventional cardiology. EuroIntervention. 2010;6:19–23. - PubMed

LinkOut - more resources